Boehringer effort targets sports fans

Share this article:
Boehringer Ingelheim is sponsoring a star-studded COPD awareness effort with NASCAR, the American Lung Association and the COPD Foundation.

The Drive4COPD campaign, a multiyear initiative aimed at promoting awareness of the need for early detection of COPD, features NASCAR driver Danica Patrick, actor Jim Belushi, Olympic medalist Bruce Jenner, musician Patty Loveless and football great Michael Strahan. All have close family members affected by bronchitis or emphysema.

Loveless kicked off the campaign Feb. 13 with her performance at Daytona International Speedway of a song she composed for the campaign remembering her older sister Dottie, who died of emphysema at age 48. Then, after a loop around the track, the campaign's celebrity drivers set off on a 6,000 mile tour for COPD awareness that will see them put in appearances at local screening events at NASCAR races, major sporting events, country music concerts and in PSAs and congressional briefings throughout the year.

The goal of the effort is to get 1 million Americans to take a five-question screener. An estimated half of the 24 million people in the US with COPD remain undiagnosed.

“I remember how my grandma struggled to breathe and how it limited her life,” said Patrick, whose grandmother suffered from emphysema. “That's why our goal is to get at least 1 million people to take a five-question screener to find out if they may be at risk for COPD and talk to their doctor.”

Boehringer Ingelheim's respiratory franchise includes Spiriva, Combivent, Atrovent, Berodual, Bronchodual, Duovent and the Respimat Soft Mist Inhaler.

“We've worked in this space for a long time and we know there's a tremendous lack of awareness around this disease,” said a Boehringer Ingleheim spokeswoman. She declined to say how much the company was spending on the campaign.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?